BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis

  Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) (“Dermata” or the “Company”), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis.

  January 4, 2024

   · 

  5 min read
• BioMidwest

  Axogen Announces Promotions on Research and Development TeamCompany Also Announces Departure of Angelo Scopelianos, Ph.D.

  Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced the promotions of three research and development team members.

  January 4, 2024

   · 

  8 min read
• Business

  Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook

  Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced a summary of 2023 accomplishments and provided guidance for anticipated upcoming 2024 milestones.

  January 4, 2024

   · 

  6 min read
• Business

  Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues

  Pacira BioSciences, Inc. reported preliminary unaudited total revenue of $675.0 million for the year ended December 31, 2023, compared with $666.8 million for the year ended December 31, 2022.

  January 4, 2024

   · 

  13 min read